BD Hylok™ glass pre-fillable syringe

Choose innovation for hyaluronic acid and intravenous drugs

The BD Hylok™ glass pre-fillable syringe* is a new luer syringe for the administration of viscous and IV drugs. It offers customers the advantages of glass containers (e.g., medication stability) with a robust luer connection. The first targeted application for the BD Hylok syringe is hyaluronic acid and more specifically, dermal fillers. For IV injected drugs, the BD Hylok syringe is a ready-to-use glass solution, compatible with main IV connectors.

Terminal steam sterilization

The syringe is designed for terminal steam sterilization at 121°C/20 minutes.1

Various sizing

The syringe is available in sizes from 1-mL long to 20 mL in different tip cap formulations and plunger stoppers.

Ergonomic and compliant design

The syringe is inclusive of human factors and the latest regulatory requirements as part of the connection design.2

Compatibility

The syringe is compatible with existing packaging and filling lines.

Screw-on tip cap

It features an easy-to-use and intuitive tip cap with proven user preference.3,4


Robust connection

It forms a robust connection with leading needleless access devices (NLADs).3,5


Luer-lok enlarged channel (LLEC)

The LLEC reduces risk of clogging in the syringe.


100% glass barrel

The all-glass barrel limits risks and costs associated with potential container changes.


New luer-lock adapter (LLA) thread design

The new LLA design reduces risk of spontaneous connector disconnection.5


New bonding technology

The new technology reduces risk of LLA disconnection or rotation.1


Components

Related Products



Notes

* The BD Hylok syringe is under development. The statements made hereunder are subject to a variety of risks and uncertainties.

References
  1. Design verification results. Pont-de-Claix, FR: Becton, Dickinson and Company; 2016.
  2. BD Hylok design input [product specifications]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2014.
  3. BD Hylok human factor study [internal report]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2015.
  4. BD Hypak PRTC human factor study [internal report]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2015.
  5. IV connectors and needle compatibility test [internal report]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2016.